Pelage Pharmaceuticals
Los Angeles, US · Delaware corporation · 4 known investors
Find your way into Pelage Pharmaceuticals
276 people in our graph share verified history with the Pelage Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Michael Taylorunlockedknows Daniel Gil · together at University of Pennsylvania (overlapped)
×3knows the team · via University of Pennsylvania
knows the team · via Pelage
×4knows the team · via Harvard University
×2knows the team · via Allergan
knows the team · via UC Irvine
Founders & leadership
WE
DG
Daniel GilinCo-founderDaniel Gil led pharmaceutical research and early-stage clinical development across ophthalmology, neuroscience, and dermatology at Allergan, where he advanced drug candidates through clinical development and authored peer-reviewed research articles. He is now Executive Officer and Director at Pelage Pharmaceuticals.
HC
Heather ChristofkCo-founder
Board
CF
Investors · 4
Reported raises · per SEC filings
Form D private placements$150.7M disclosed across 3 rounds · 2023–2025
▶$120MraisedNov 2025 · 5 investors · PharmaceuticalsRule 506(b)
▶$120MraisedNov 2025 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cathy FriedmanDirector
- Nathan WheelerExecutive Officer
- William Edward LowryExecutive Officer, Director
- Christina WengExecutive Officer
- Daniel GilExecutive Officer, Director
- Richard HeymanDirector
- Offering amount
- $120M
- Amount sold
- $120M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedAug 2024 · 6 investors · PharmaceuticalsRule 506(b)
▶$14MraisedAug 2024 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cathy FriedmanDirector
- William Edward LowryDirector
- Daniel GilExecutive Officer, Director
- Heather ChristofkExecutive Officer
- Offering amount
- $14M
- Amount sold
- $14M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.7MraisedJun 2023 · 6 investors · PharmaceuticalsRule 506(b)
▶$16.7MraisedJun 2023 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cathy FriedmanDirector
- Heather ChristofkExecutive Officer
- William Edward LowryDirector
- Daniel GilExecutive Officer, Director
- Offering amount
- $16.7M
- Amount sold
- $16.7M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Pelage Pharmaceuticals?
- Pelage Pharmaceuticals was founded by William Edward Lowry, Daniel Gil, Heather Christofk.
- Who are Pelage Pharmaceuticals's investors?
- Pelage Pharmaceuticals's investors include ARCH Venture Partners, GV (Google Ventures), Visionary Ventures, YK Bioventures.
- How much funding has Pelage Pharmaceuticals raised?
- Pelage Pharmaceuticals has disclosed $150.7M raised across 3 rounds.
- Where is Pelage Pharmaceuticals headquartered?
- Pelage Pharmaceuticals is headquartered in Los Angeles, US.